Drugs / MG1-E6E7
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03618953 | Jun 2018 → Mar 2021 | virus associated tumor | Turnstone Biologics, Corp. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MG1-E6E7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03618953 ↗ |
| Route | Intravenous | “MG1-E6E7 administered as 4 infusion (IV) doses” NCT03618953 ↗ |